These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27774604)

  • 1. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
    Ma S; Smith CM; Blasiak A; Gundlach AL
    Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.
    Kumar JR; Rajkumar R; Jayakody T; Marwari S; Hong JM; Ma S; Gundlach AL; Lai MKP; Dawe GS
    Br J Pharmacol; 2017 May; 174(10):1061-1076. PubMed ID: 27597467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal.
    Hosken IT; Sutton SW; Smith CM; Gundlach AL
    Behav Brain Res; 2015 Feb; 278():167-75. PubMed ID: 25257104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.
    Smith CM; Shen PJ; Banerjee A; Bonaventure P; Ma S; Bathgate RA; Sutton SW; Gundlach AL
    J Comp Neurol; 2010 Oct; 518(19):4016-45. PubMed ID: 20737598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
    Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
    Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
    Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
    Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades.
    Rahman MT; Chaminda Lakmal HH; Hussain J; Jin C
    Expert Opin Ther Pat; 2024; 34(1-2):71-81. PubMed ID: 38573177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
    Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
    Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of central relaxin-3 signalling in sodium (salt) appetite.
    Smith CM; Walker LL; Chua BE; McKinley MJ; Gundlach AL; Denton DA; Lawrence AJ
    Exp Physiol; 2015 Sep; 100(9):1064-72. PubMed ID: 26147879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.
    Kania A; Gugula A; Grabowiecka A; de Ávila C; Blasiak T; Rajfur Z; Lewandowski MH; Hess G; Timofeeva E; Gundlach AL; Blasiak A
    J Physiol; 2017 Jun; 595(11):3425-3447. PubMed ID: 28098344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice.
    Smith CM; Chua BE; Zhang C; Walker AW; Haidar M; Hawkes D; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Gundlach AL
    Behav Brain Res; 2014 Jul; 268():117-26. PubMed ID: 24681162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity.
    Jayakody T; Marwari S; Lakshminarayanan R; Tan FC; Johannes CW; Dymock BW; Poulsen A; Herr DR; Dawe GS
    Peptides; 2016 Oct; 84():44-57. PubMed ID: 27498038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice.
    Zhang C; Chua BE; Yang A; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Smith CM; Gundlach AL
    Behav Brain Res; 2015 Oct; 292():125-32. PubMed ID: 26057358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
    DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
    Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin-3 inputs target hippocampal interneurons and deletion of hilar relaxin-3 receptors in "floxed-RXFP3" mice impairs spatial memory.
    Haidar M; Guèvremont G; Zhang C; Bathgate RAD; Timofeeva E; Smith CM; Gundlach AL
    Hippocampus; 2017 May; 27(5):529-546. PubMed ID: 28100033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a selective agonist for relaxin family peptide receptor 3.
    Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
    Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
    Agoulnik AI; Agoulnik IU; Hu X; Marugan J
    Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific effects of relaxin-3 on food intake and body weight gain.
    Calvez J; de Ávila C; Timofeeva E
    Br J Pharmacol; 2017 May; 174(10):1049-1060. PubMed ID: 27245781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat.
    Ryan PJ; Büchler E; Shabanpoor F; Hossain MA; Wade JD; Lawrence AJ; Gundlach AL
    Behav Brain Res; 2013 May; 244():142-51. PubMed ID: 23380674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.